BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34114357)

  • 1. Identification and Evaluation of Serum Protein Biomarkers That Differentiate Psoriatic Arthritis From Rheumatoid Arthritis.
    Mc Ardle A; Kwasnik A; Szentpetery A; Hernandez B; Parnell A; de Jager W; de Roock S; FitzGerald O; Pennington SR
    Arthritis Rheumatol; 2022 Jan; 74(1):81-91. PubMed ID: 34114357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discovery.
    McArdle A; Qasim Butt A; Szentpetery A; de Jager W; de Roock S; FitzGerald O; Pennington SR
    Proteomics Clin Appl; 2016 Jun; 10(6):691-8. PubMed ID: 26332844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating Mir-140 and leptin improve the accuracy of the differential diagnosis between psoriatic arthritis and rheumatoid arthritis: a case-control study.
    Cheleschi S; Tenti S; Bedogni G; Fioravanti A
    Transl Res; 2022 Jan; 239():18-34. PubMed ID: 34380068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of proteins with heparin affinity in patients with rheumatoid and psoriatic arthritis: a preliminary study.
    Grazio S; Razdorov G; Erjavec I; Grubisic F; Kusic Z; Punda M; Anticevic D; Vukicevic S; Grgurevic L
    Clin Exp Rheumatol; 2013; 31(5):665-71. PubMed ID: 23739182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach.
    de Seny D; Fillet M; Meuwis MA; Geurts P; Lutteri L; Ribbens C; Bours V; Wehenkel L; Piette J; Malaise M; Merville MP
    Arthritis Rheum; 2005 Dec; 52(12):3801-12. PubMed ID: 16320331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity.
    Inciarte-Mundo J; Ramirez J; Hernández MV; Ruiz-Esquide V; Cuervo A; Cabrera-Villalba SR; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Res Ther; 2016 Jul; 18(1):160. PubMed ID: 27391315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential synovial tissue biomarkers among psoriatic arthritis and rheumatoid factor/anti-citrulline antibody-negative rheumatoid arthritis.
    Alivernini S; Bruno D; Tolusso B; Bui L; Petricca L; Gigante MR; Birra D; Fedele AL; Peluso G; Federico F; Ferraccioli G; Gremese E
    Arthritis Res Ther; 2019 May; 21(1):116. PubMed ID: 31072400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the serum metabolome and lipidome identify potential biomarkers for seronegative rheumatoid arthritis versus psoriatic arthritis.
    Souto-Carneiro M; Tóth L; Behnisch R; Urbach K; Klika KD; Carvalho RA; Lorenz HM
    Ann Rheum Dis; 2020 Apr; 79(4):499-506. PubMed ID: 32079570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Fecal Metabolomics and Potential Biomarkers of Psoriatic Arthritis Differing From Rheumatoid Arthritis.
    Wang N; Yang L; Shang L; Liang Z; Wang Y; Feng M; Yu S; Li X; Gao C; Li Z; Luo J
    Front Immunol; 2022; 13():812996. PubMed ID: 35296075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calprotectin as a marker of ultrasound-detected synovitis in early psoriatic and rheumatoid arthritis: results from a cross-sectional retrospective study.
    Sakellariou G; Lombardi G; Vitolo B; Gomarasca M; Faraldi M; Caporali R; Banfi G; Montecucco C
    Clin Exp Rheumatol; 2019; 37(3):429-436. PubMed ID: 30299248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Proposed Serum Calprotectin IgG Cut-Off Level for Diagnosing Inflammatory Arthritis.
    Grossi V; Infantino M; Manfredi M; Meacci F; Bellio E; Bellio V; Gobbi FL; Ugolini S; Catani S; Sarzi-Puttini P; Atzeni F; Benucci M
    Curr Rheumatol Rev; 2017; 13(2):93-97. PubMed ID: 27363504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galectin-1 in Psoriatic arthritis, Psoriasis, Rheumatoid arthritis and its relation with disease activity and skin lesion.
    El Bably MM; Abdel Aziz DM; Adly NN; Ali MA; Khedr AS; El Leithy SA
    Egypt J Immunol; 2023 Apr; 30(2):73-82. PubMed ID: 37031409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Swedish early psoriatic arthritis register-- 2-year followup: a comparison with early rheumatoid arthritis.
    Lindqvist UR; Alenius GM; Husmark T; Theander E; Holmström G; Larsson PT;
    J Rheumatol; 2008 Apr; 35(4):668-73. PubMed ID: 18278834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.
    Jadon DR; Sengupta R; Nightingale A; Lu H; Dunphy J; Green A; Elder JT; Nair RP; Korendowych E; Lindsay MA; McHugh NJ
    Arthritis Res Ther; 2017 Sep; 19(1):210. PubMed ID: 28934972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subclinical impairment of myocardial and endothelial functionality in very early psoriatic and rheumatoid arthritis patients: Association with vitamin D and inflammation.
    Lo Gullo A; Rodríguez-Carrio J; Aragona CO; Dattilo G; Zito C; Suárez A; Loddo S; Atteritano M; Saitta A; Mandraffino G
    Atherosclerosis; 2018 Apr; 271():214-222. PubMed ID: 29524864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin A antibodies to oxidized collagen type II as a potential biomarker for the stratification of spondyloarthritis from rheumatoid arthritis.
    Vinci C; Infantino M; Raturi S; Tindell A; Topping LM; Strollo R; Amital H; Shoenfeld Y; Gertel S; Grossi V; Manfredi M; Rutigliano IM; Bandinelli F; Li Gobbi F; Damiani A; Pozzilli P; Mcinnes IB; Goodyear CS; Benucci M; Nissim A
    Scand J Rheumatol; 2020 Jul; 49(4):281-291. PubMed ID: 32314641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory findings in psoriatic arthritis.
    Punzi L; Podswiadek M; Oliviero F; Lonigro A; Modesti V; Ramonda R; Todesco S
    Reumatismo; 2007; 59 Suppl 1():52-5. PubMed ID: 17828345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of antibodies against mutated citrullinated vimentin for rheumatoid arthritis.
    Besada E; Nikolaisen C; Nossent H
    Clin Exp Rheumatol; 2011; 29(1):85-8. PubMed ID: 21269572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations Between Five Important Domains of Health and the Patient Acceptable Symptom State in Rheumatoid Arthritis and Psoriatic Arthritis: A Cross-Sectional Study of 977 Patients.
    Puyraimond-Zemmour D; Etcheto A; Fautrel B; Balanescu A; de Wit M; Heiberg T; Otsa K; Kvien TK; Dougados M; Gossec L
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1504-1509. PubMed ID: 27998030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low serum hyaluronan in psoriatic arthritis patients in comparison to rheumatoid arthritis patients.
    Partsch G; Leeb B; Stancikova M; Raffayova H; Eberl G; Hitzelhammer H; Smolen JS
    Clin Exp Rheumatol; 1996; 14(4):381-6. PubMed ID: 8871836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.